Author/Creator: Dodds, M. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Dodds, M.

1. AMG 151 (ARRY‐403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes. Issue 2 (14th December 2015)

Authors:: Katz, L.; Manamley, N.; Snyder, W. J.; Dodds, M.; Agafonova, N.; Sierra‐Johnson, J.; Cruz, M.; Kaur, P.; Mudaliar, S.; Raskin, P.; Kewalramani, R.; Pellacani, A.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 18:Issue 2(2016)
Page Start:: 191
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of target-mediated elimination on evolocumab dose and regimen. Issue 1 (July 2015)

Authors:: Gibbs, J.P.; Grover, A.; Emery, M.G.; Dodds, M.; Somaratne, R.; Wasserman, S.M.
Journal:: Atherosclerosis
Issue:: Volume 241:Issue 1(2015)
Page Start:: e197
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of target-mediated elimination on evolocumab dose and regimen. Issue 1 (July 2015)

Authors:: Gibbs, J.P.; Grover, A.; Emery, M.G.; Dodds, M.; Somaratne, R.; Wasserman, S.M.
Journal:: Atherosclerosis
Issue:: Volume 241:Issue 1(2015)
Page Start:: e197
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗